LiveNova Logo

TandemLife is now a part of LivaNova, Learn More Here.

COVID-19 UPDATES:The U.S. Food and Drug Administration (FDA) issued guidance on April 6, 2020 to temporarily expand the availability of devices used in extracorporeal membrane oxygenation (ECMO) therapy to address the novel coronavirus (COVID-19) public health emergency. As a result of the guidance, cardiopulmonary devices, including select devices from TandemLife | LivaNova, are now temporarily indicated for ECMO therapy greater than 6 hours. To read the full announcement, click here.



855 336 3051 REIMBURSEMENT

800 373 1607 US

412 507 6182 INTERNATIONAL

LifeSPARC System logo

Life support simplified.

For more patients, in more places. Built on more than 20 years of life support experience with TandemLife, LifeSPARC provides temporary support for emergent rescue patients in a variety of hospital settings.

The system is built around a common compact console and pump, and four ready-to-deploy kits. Designed for ease of use, LifeSPARC offers more power and versatility for multi-disciplinary programs to support more patients.



Millions of patients are affected by cardiac and respiratory disease each year. LifeSPARC is designed to ensure that more of those patients can be supported with a system that is easy enough for new practitioners and powerful enough for expert-level hospital centers.

LifeSPARC leverages a common compact console and pump to temporarily support emergent rescue patients in a variety of hospital settings. The system offers a streamlined user interface and 40% more power despite a smaller, lighter controller which is half the size of the previous generation.

The LifeSPARC system offers a new streamlined experience for users versus the previous generation. The new platform includes simple solutions to help simplify temporary cardiopulmonary bypass so that more patients have access to this high degree of support.

*In the U.S., the LifeSPARC system is intended to pump blood through an extracorporeal circuit for periods lasting less than six hours for the purpose of providing either: (i) full or partial cardiopulmonary bypass (i.e., circuit includes an oxygenator) during open surgical procedures on the heart or great vessels; or (ii) temporary circulatory bypass for diversion of flow around a planned disruption of the circulatory pathway necessary for open surgical procedures on the aorta or vena cava.

LifeSPARC Upgrades include:

  • Up to 8.0 L/m of flow compared to 5.0 L/m
  • Increased power
  • Only sterile on-patient pump without infusion line
  • Quick prime
  • Lightweight & portable
  • Simple user interface

Become an early LifeSPARC adopter

LifeSPARC Platform Components



LifeSPARC is ideal for multi-disciplinary programs. A lightweight controller and docking station featuring four simple screens are built to help manage patients with confidence. The streamlined user interface helps minimize the learning curve and training can be supplemented with the XL Alliance Training programs.



The pump is designed for a rapid, repeatable deployment process, an essential factor to initiate advanced circulatory support in diverse clinical environments. A small but powerful pump, capable of 8LPM of blood flow, with a magnetic bearing, supports a variety of cardiac and respiratory rescue conditions. The integrated pump head and motor can be placed in the sterile field and on the patient, reducing the overall circuit surface area, simplifying patient management.



The LifeSPARC system can be primed in minutes enabling temporary circulatory support anywhere and anytime it is needed. With a two-hour battery backup, the LifeSPARC controller can be removed from the docking station and carried via strap to make in-hospital transport less cumbersome.

LifeSPARC Kits

LifeSPARC Kits

The LifeSPARC system is complemented by four specialized kits that enable a variety of cannulation strategies with:

• ProtekDuo LS
• TandemHeart LS
• TandemLife LS
• TandemLung LS